Tuberculosis and Nontuberculous Mycobacterial Infections Ed 7

For Tuberculosis and Nontuberculous Mycobacterial Infections, Dr. Schlossberg assembled an international team of experts to write about nearly every facet of the prevention, diagnosis, and treatment of tuberculosis and nontuberculous mycobacterial infections. In addition to presenting the latest clinical data, epidemiological findings, and policy and strategy recommendations of the World Health Organization, four new chapters cover topics of critical importance:
The role of therapeutic drug monitoring in mycobacterial infections
The public health issues of refugees and migrants, and their exposure and transmission of tuberculosis resulting from humanitarian crises
Diabetes mellitus as a significant risk factor for tuberculosis
The increased risk of tuberculosis reactivation in people taking tumor necrosis factor alpha inhibitors and other biopharmaceuticals Other chapters provide detailed information on the clinical, public health, and policy aspects of tracking and treating tuberculosis, including:
The many presentations of tuberculosis, from pulmonary to ocular and cardiovascular to urogenital
The complications that tuberculosis and antituberculosis therapy cause to the hematologic and endocrine systems
Tuberculosis during pregnancy and in infants and children
Treatment of multidrug-resistant tuberculosis and extensively drugresistant tuberculosis
Development of new vaccines
Nontuberculous infections caused by mycobacteria found throughout our environment
The seventh edition of Tuberculosis and Nontuberculous Mycobacterial Infections is an essential resource for anyone working to prevent and treat tuberculosis and associated infections, from infectious disease specialists to scientists, policymakers, and epidemiologists.